Cancer vaccines to witness a significant growth in the forecast period 2016-2021

According to the report "Cancer Vaccines Market", published by Market Data Forecast, the global market is projected to reach USD 6.28 billion by 2021, at a CAGR of 17.11 % from 2016 to 2021.

For full report refer to http://www.marketdataforecast.com/market-reports/global-cancer-vaccines-market-1419/

Similar to the vaccines which are used mostly for the inhibition of contagious diseases by improving the immune response against pathogens, cancer vaccines are used to activate the immune system to attack the cancer cells. Cancer therapeutic vaccines helps in alleviating the patients suffering from cancer. With the new technological advances, cancer vaccines have been developed as a new therapeutic way for cancer prevention and eradication.

Free sample of the report is available at http://www.marketdataforecast.com/market-reports/global-cancer-vaccines-market-1419/request-sample

The Key drivers of the market are rising number of people with cancer, increasing public awareness of vaccines, smoking and excessive alcoholic intake, and presence of strong late-stage pipeline Vaccines, vendors' patient-assistance programs. Stringent regulations for the approval, Vaccines costs are the major restraints that hamper the growth of the Cancer vaccines market.

Market Segmentation:

Based on Cancer Type:
• Prostate
• Cervical
• Colorectal
• Throat
• Others

Based on Vaccine Type:
• Antigen
• Tumour cell
• Dendritic cell
• Other vaccines

Based on End Users:
• Cancer Treatment Centres
• Research Institutes

Based on Geography
• North America
• Europe
• Asia – Pacific
• Latin America
• Middle East & Africa

Some of the major companies dominating the global market are Dendreon, GlaxoSmithKline and Merck. Other companies whose products are in pipeline stage are Aduro Biotech, Advantagene, Advaxis, Agenus, Altor BioScience, Argos Therapeutics, AVAX Technologies, Bavarian Nordic, Biothera, Celldex Therapeutics, CureVac, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics.

About us
Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organisation that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.

Contact Us:
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 9985550206
Mail: abhishek@marketdataforecast.com
Jubilee Gardens,
Hyderabad, India.

This release was published on openPR.